Kota Tsuruya

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Clinical Practice

Psychometric Properties

Acute Heart Failure

Pulmonary Arterial Hypertension

Top Venues

BMJ open gastroenterology

Hepatology research : the official journal of the Japan Society of Hepatology

Clinical and experimental gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Atsushi Tanaka, Keiji Tsuji, Yasuyuki Komiyama, Kota Tsuruya, Keisuke Kakisaka, Akemi Tsutsui, Keiko Ichimoto, Masayuki Ueno, Yuki Okazaki, Hiroteru Kamimura, Atsushi Takai, Noriyo Yamashiki, Takanori Ito, Masaaki Watanabe, Masanori Abe, Ken-Ichi Harada, Tatehiro Kagawa
RECAM-J 2023-Validation and development of the Japanese version of RECAM for the diagnosis of drug-induced liver injury. Hepatology research : the official journal of the Japan Society of Hepatology (2024)
Atsushi Tanaka, Keiji Tsuji, Yasuyuki Komiyama, Kota Tsuruya, Keisuke Kakisaka, Akemi Tsutsui, Keiko Ichimoto, Masayuki Ueno, Yuki Okazaki, Hiroteru Kamimura, Atsushi Takai, Noriyo Yamashiki, Takanori Ito, Masaaki Watanabe, Masanori Abe, Ken-Ichi Harada, Tatehiro Kagawa
RECAM-J 2023-Validation and development of the Japanese version of RECAM for the diagnosis of drug-induced liver injury. Hepatology research : the official journal of the Japan Society of Hepatology 54 (6) (2024)
Atsushi Tanaka, Keiji Tsuji, Yasuyuki Komiyama, Kota Tsuruya, Keisuke Kakisaka, Akemi Tsutsui, Keiko Ichimoto, Masayuki Ueno, Yuki Okazaki, Hiroteru Kamimura, Atsushi Takai, Noriyo Yamashiki, Takanori Ito, Masaaki Watanabe, Masanori Abe, Ken-Ichi Harada, Tatehiro Kagawa
RECAM-J 2023-Validation and development of the Japanese version of RECAM for the diagnosis of drug-induced liver injury. Hepatology research : the official journal of the Japan Society of Hepatology 54 (6) (2024)
Kota Tsuruya, Jun Koizumi, Yuka Sekiguchi, Shun Ono, Tatsuya Sekiguchi, Takuya Hara, Yusuke Mishima, Yoshitaka Arase, Shunji Hirose, Koichi Shiraishi, Tatehiro Kagawa
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan. BMJ open gastroenterology 10 (1) (2023)
Kota Tsuruya, Jun Koizumi, Yuka Sekiguchi, Shun Ono, Tatsuya Sekiguchi, Takuya Hara, Yusuke Mishima, Yoshitaka Arase, Shunji Hirose, Koichi Shiraishi, Tatehiro Kagawa
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan. BMJ open gastroenterology 10 (1) (2023)
Kota Tsuruya, Jun Koizumi, Yuka Sekiguchi, Shun Ono, Tatsuya Sekiguchi, Takuya Hara, Yusuke Mishima, Yoshitaka Arase, Shunji Hirose, Koichi Shiraishi, Tatehiro Kagawa
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan. BMJ open gastroenterology 10 (1) (2023)
Kota Tsuruya, Jun Koizumi, Yuka Sekiguchi, Shun Ono, Tatsuya Sekiguchi, Takuya Hara, Yusuke Mishima, Yoshitaka Arase, Shunji Hirose, Koichi Shiraishi, Tatehiro Kagawa
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan. BMJ open gastroenterology 10 (1) (2023)
Kota Tsuruya, Jun Koizumi, Yuka Sekiguchi, Shun Ono, Tatsuya Sekiguchi, Takuya Hara, Yusuke Mishima, Yoshitaka Arase, Shunji Hirose, Koichi Shiraishi, Tatehiro Kagawa
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan. BMJ open gastroenterology 10 (1) (2023)
Kota Tsuruya, Jun Koizumi, Yuka Sekiguchi, Shun Ono, Tatsuya Sekiguchi, Takuya Hara, Yusuke Mishima, Yoshitaka Arase, Shunji Hirose, Koichi Shiraishi, Tatehiro Kagawa
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan. BMJ open gastroenterology 10 (1) (2023)
Makoto Chuma, Haruki Uojima, Nobuhiro Hattori, Yoshitaka Arase, Taito Fukushima, Shunji Hirose, Satoshi Kobayashi, Makoto Ueno, Shun Tezuka, Shuichiro Iwasaki, Naohisa Wada, Kousuke Kubota, Kota Tsuruya, Yoshimasa Shimma, Ikeda Hiroki, Ehira Takuya, Chikako Tokoro, Shigeru Iwase, Yuki Miura, Satoshi Moriya, Tsunamasa Watanabe, Hisashi Hidaka, Manabu Morimoto, Kazushi Numata, Chika Kusano, Tatehiro Kagawa, Shin Maeda
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis. Hepatology research : the official journal of the Japan Society of Hepatology (2021)
Kota Tsuruya, Kazuya Anzai, Shunsuke Shioyama, Ayano Ito, Yoshitaka Arase, Shunji Hirose, Yasuhito Tanaka, Hidekazu Suzuki, Tatehiro Kagawa
Case of hepatitis B virus reactivation after ibrutinib therapy in which the patient remained negative for hepatitis B surface antigens throughout the clinical course. Hepatology research : the official journal of the Japan Society of Hepatology 51 (2) (2020)
Shunji Hirose, Koshi Matsumoto, Masayuki Tatemichi, Kota Tsuruya, Kazuya Anzai, Yoshitaka Arase, Koichi Shiraishi, Michiko Suzuki, Satsuki Ieda, Tatehiro Kagawa
Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients. PloS one 15 (11) (2020)
Katsuaki Ogushi, Masanori Atsukawa, Haruki Uojima, Hisashi Hidaka, Kazushi Numata, Satoshi Kobayashi, Shunji Hirose, Nobuhiro Hattori, Tomoaki Fujikawa, Takahide Nakazawa, Naohisa Wada, Shuitirou Iwasaki, Taito Fukushima, Yusuke Sano, Makoto Ueno, Kuniyuki Kawano, Kota Tsuruya, Masako Shomura, Tsunamasa Watanabe, Kotaro Matsunaga, Yosuke Kunishi, Yusuke Saigusa, Kuniyasu Irie, Shogo Iwabuchi, Makoto Kako, Manabu Morimoto, Tatehiro Kagawa, Katsuaki Tanaka, Shin Maeda
Safety and Efﬁcacy of Lenvatinib Treatment in Child-Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis. Clinical and experimental gastroenterology 13 (2020)